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ABS.T
The genarnes of mnmerous avian retroviruses contain at their 3'
termini a conserved danain denoted "c". The precise boundaries and
function of "c" have been enigmas. In an effort to resolve these is-
sues, we determined the sequence of ovrer 900 rncleotides at the 3' end
of the genom of the Schmidt-Ruppin subgroup A strain of avian sarcoa
virus (ASV). We obtained the sequence from a suitable fragment of ASV
IX that had been cloned into the single-stranded E phage M13np2.
Coputer-assisted analysis of the sequence revealed the following
structural features: i) the length of mc" - 473 nucleotides; ii) the
3' terminal domain of src, ending in an amber codon at the 5' boundary
of "c"; iii) terminator Cdons that preclude continuous translation
from "c"; iv) suitably located sequences that my serve as signals for
the initiaticn of viral RIA synthesis and for the processing and/or
polyadenylaticn of viral M; v) a repeated sequence that flanks src
and that could facilitate deletion of this gene; vi) repeated se
quences within wc"; and vii) unexplained hanologies between sequences
in "c" and sequences in several other reicacids, including the 5'
terminal dmairt.W the ASV genomae, tR and its inversion, the coo-
plenwt of tR4 and its inversion, and the 18S MA of eukaryotic
rib--ones. We conclude that "c" probably does not encode a protein,
but its sequence may nevertheless serve several essential functions in
viral replication.
m1e haploid gerxne of avian saroma virus (ASV) is a single-
stranded RI conpoxed of ca. 9500 nucleotides (1). This RW fills tw
roles during the viral life cycle. First, it serves as niM for the
synthesis of several viral polypeptides (1); accordingly, the RM is
capped (2) and polyaderylated (3) at the 5' and 3' termini, respec-
tively. Second, the viral genane is the tenplate for synthesis of
viral CMz by reverse transcriptase (1,4); the product of this syn-
thesis is integrated into the gerxne of the host cell and transcribed
into progeny viral RA (1,5). Tw structural features of the viral
genome have been inplicated in the synthesis of viral DNA: a molecule
of tRaTrP located near the 5' end of the viral RIA serves as primer
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for reverse transcriptase (6); and a sequence of 16-21 nucleotides,
repeated directly at the tw ends of the viral genome (7,8,28), medi-
ates early events in propagation of the nascent C chain (4,7-9,28;
R.S., manuscript in preparation). The integrated E (or "provirus")
of ASV is coextensive with viral RPM but, in addition, contains a
330p terminal redundancy copoed of nucleotide sequences derived
from both the 3' and 5' ends of the viral genome (10,11). The redun-
dant sequences may serve either or both of two purposes: they may
mediate integration; and they may harbor the promoter for viral RA
synthesis.
mEhe genome of ASV contains four identified genes, arranged as
follows on the viral MA: 5'- g-ag-env-src -3' (1). The genes M,
Et and env are required for viral replication, whereas src is devoted
exclusively to necplastic transformation of the host cell (12). In
addition, structural studies have identified a conserved dcmain locat-
ed to the right of src, coupoed of ca. 500 nucleotides, and denoted
"cm because of its presence in numerous strains of avian retroviruses
(13,14).
Tw distinctive functions have been attributed to "c". On the one
hand, recarbination analysis indicated that the sequence may be inpor-
tant for viral replication (15,16). On the other hand, some investi-
gators have sought to inplicate "c" in leukemogenesis by avian leu-
kosis viruses, which otherwise have no apparent genetic locus devoted
to tunmrigenesis (1,17,18). In order to explore the structural boun-
daries and possible functions of "c", we have determined the sequence
of over 900 rucleotides at the 3' end of the genome of the Schmidt-
RLppin sugroup A strain of ASV (SR-A ASV).
Our experimetal strategy exploited the fact that we had previ-
ously cloned the entire gerxne of SR-A ASV into both phage and plasmid
vectors (19). From these clones, we isolated a 3.2kb EBo RI fragment
of MA that contained all but 65 nucleotides of "c", the entirety of
src, and ca. l.Okb to the left of src. We then cloned this EA into
the single-stranded wphage Ml3np2 (20,21) in order to facilitate
sequence analysis by the "chain terminator technique" developed by
Sanger and colleagues (22). Supplanentary data were also obtained by
the sequencing procedure of Maxam and Gilbert (23), and with CM iso-
lated from plasmid sb-clones of SR-A ASV WA. Our results indicate
that "c" is probably not expressed by translation into a protein. In
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a-dditicn, we have found suitably located nucleotide sequences that may
serve as signals for the initiation of viral RNA synthesis and the po-
lyadenylaticn of viral RNA. We encountered unexpected and non-random
homnlogies between sequences in "c" and sequences in tR7r , its po-
lyrucleotide conplement, and the 5' end of the ASV genome. Several of
our conclusions conform to a recent report that contained the sequence
of 217 nucleotides in the "c" domain of the Schmidt-Ruppin subgroup D
strain of ASV (24).
MATORIALS ANDM E
Materials
Most of the materials have been described previously (19-23,25).
All of the restriction enzymes were from New England Biolabs Inc. and
were used as reccmended. The synthetic dodecanucleotide
d(VACNGCiTWrG) was obtained from Collaborative Research. This oli-
gonucleotide is conplementary to a sequence within the lac region of
M13np2 and can be used as a universal primer for the sequencing of DNA
joined to the lac region at the Eco RI cloning site (20,21). The
Klenow fragment of polymerase I and polynucleotide kinase were from
Boehringer Mannheim, and the ei32PP and )32PATP from Amersham
(specific activity ca. 400 rCi/nml and 3000 Ci/nurl respectively).
Clcnipg_ceure: The viral DNA of SR-A was cloned previously into
the vector Xgt%EW4B (19). Treatment of the cloned DM with Eoo RI
generates the following fragments: 2.0kb, 3.9kb, 3.2kb, 0.33kb, and
0.26kb. We used for our cloning purposes the fragment of 3.2kb. DM
for cloning was usually obtained by Boo RI treatment of the recm-
binant phage DN and subsequent separation of the fragments on a 1%
agarose gel. The DN was localized by staining with ethidium bromide
and by reference to appropriate markers and was then recovered by
electroeluticn (25). C was cloned into Ml3np2 and recovered as
recombinant phage genome or replicative form as described previously
(20,21,25). The phage vector and its host, E. coli strain JM101,
were provided by J. Messing. All work with reconbinant DN was per-
formed according to NIH guidelines in certified P2 and P3 facilities.
Hybridizatin procedures: For hybridization with -D transferred to
nitrocellulose filters we used two different probes: i) cDNArep, which
was prepared as described previously (26,27), using the gencme of
Prague-C ASV as template. This cDNA contains mainly single-stranded
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of regative polarity (ie., conpiementary to the ASV genome) and
ws used for screening recuxrbinant plaques and for identification of
the polarity of the single-stranded viral DNA cloned into M13np2. ii)
A probe for nucleotide sequences represented in the 3.2kb Eboo RI frag-
ment of ASV E was prepared by transcribing the denatured fragment
with reverse transcriptase in the presence of random oligodecoynucleo-
tide primers, as described previously (19,27,28). EIAs were
transferred from agarose gels to nitrocellulose filters and hybridized
with radioactive cEls (29).
Isolaticn of primers for sequencing reactions: The 3.2kb fragment of
ASV El was isolated from the lantbda clone described above, from a
sub-clone in pBR322, or from the replicative form of a sub-clone in
M13np2. mfhe purified fragment was cleaved with suitable restriction
endonucleases; the products of digestion were fractionated by electro-
phoresis in gels of polyacrylamide or agarose, located by staining
with ethidium bromide and by reference to standard markers, and
recovered from slices of the gel by electroelution (25).
Sequencing techniques: We generally used chain termination with di-
deoxyrucleotides exactly as described by Sanger et al (22), except
that we used c32P-dAP as the radioactive precursor in all reactions.
At the conclusion of the polymerase reactions, primers were usually
renwved from the newly synthesized DM@ by cleavage with the appropri-
ate restriction endonuclease (one unit of enzyme per 20 microliters of
reaction mixture, five minutes at 37 ). Three fragments were also se-
quenced by the Maxam-Gilbert technique (23), which was used without
any nodification. ffte DMZ fragments were labeled on the 5'-end with
y32P_JP and polynucleotide kinase under standard conditions
(23), or they were labeled on their 3'-ends by copying the 5' "over-
hangs" of restriction sites with polymerse I (Klenow fragment) under
the same conditions as we used for the sequencing reaction described
above.
RESULTS
Isolation of ASV DNA for sequencing: molecular cloning in the single-
stranded ENA p Ml3np2.
We have previously cloned DEA representing the gerxnme of SR-A ASV
in the vector gttiS B (19). Hydrolysis of the chimeric DNA with
Ebo RI cleaves the ASV conpoent four times. Among the products of
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cleavage is a 3.2 kb DA fragment that extends frcan the 65th residue
of "c" (nunbering from the 3' terminus of the viral RA genome) to ca.
l.Okb to the 5' side of src (19). In work to be reported elsewhere,
we used transfection of cultured fibroblasts to demonstrate that this
DE fragment is capable of directing the synthesis of the protein en-
coded in src, and thus, of transforming recipient cells to a necplas-
tic phenotype (P. Luciw et al., manuscript in preparation); hence, the
structure and function of the src gene (and by inference, the
remainder of the DNA fragment) survived cloning and propagation in
prokaryotic vectors.
We isolated the 3.2kb IA fragment as described under Materials
and Methods; analysis by electrophoresis in an agarose gel denonstrat-
ed that the isolated fragment was homogeneous and pure (Figure la,
lane 1). The fragment was then cloned into the Eco RI site of ML3mp2.
In order to document the cc6position of positive clones, we isolated
the replicative form DNA of recambinant phage, cleaved the DA with
Eco RI, and demonstrated that the products of cleavage included a
3.2kb fragment that hybridized with ASV cDNArep (Figure la, lane 2).
We concluded that the viral DNA had survived the sub-cloning without
sustaining an appreciable deletion.
In preliminary studies of a set of sub-clones, we found that the
single-stranded genane of the chimeric phage invariably contained only
the negative strand of ASV [E; the predaninance of one polarity in
recombinant clones of M13 has been a recurrent problem in the use of
this vector (unpublished observations of the authors). In an effort
to obtain both polarities of ASV DA in the phage genane, we isolated
the replicative form of one of the recombinant clones, cleaved the DtA
with Eco RI, religated the DA and used it to transform the bacterial
host JM 101. Clones containing viral DNA were again isolated, and
some were foundl to contain a 3.2kb Eco RI fragment that hybridized
with cDL rep (data not shown).
The presence of inserted DM in the gencmes of these new phage
clones was demonstrated by electrophoresis of the single-stranded DNA
in an agarose gel; the genanes of phage derived from apparently recom-
binant clones migrated appreciably slower (Figure lb, lanes 2 and 3)
than the genane of the phage itself (Figure lb, lane 1). The electro-
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Figure 1. Preparation of cloned WS for sequence analysis.
I^s were isolated, cleaved with restriction endonucleases, frac-
tionated by electrcphoresis in agarose gels, transferred to nitrocel-
lulose filters and analysed by molecular hybridization as outlined
uder Materials and Methods.
Panel a. Sub-clning the Eoo RI 3.2kb fragment of ASV Dt. Lane 1,
the 3.2kb fragment prior to sub-cloning into Ml3np2. bhe 3.2kb frag-
ment of ASV M was purified following cleavage of recombinant CM
containing the entire ASV genome with Boo RI. A portion of the iso-
lated fragnt was analysed by electrcphoresis in a gel of 1% agarose.
The figure illustrates an autoradiogram obtained following transfer of
the [W to a nitrocellulose filter and hybridization with cUt
r
Lane 2, the 3.2kb fragment following sub-cloning into M13up2. Te Sik
fragment analysed in lane 1 was sub-cloned into Ml3np2 at the EBo RI
site. Replicative form of the sub-clone was isolated, cleavWwith
EBo RI and analysed as in lane 1. 71e figure illustrates an autora-
no-gram obtained following hybridization of the inmmbilized CM with
PaneEB: Detection of inserts in the gerou of Ml3np2. Single-
stranded M was extracted fran phage, fractionated by electrophoresis
in a gel of 1% agarose and detected by staining with ethidium bromide.
Lane 1, the genrxe of M13np2. Lanes 2 and 3, the gencmes of phage
containing inserts of ASV E.
Panel c. Detection of renccbinant clones of M13np2 containing posi-
tive strands of ASV EH. The DtNs of lanes 2 and 3 in panel b were
transferred to nitrocellulose filters and hybridized with cE1 ; the
figure illustrates autoradiogram obtained subsequent to the fiEridi-
zation.
Panel d. Detection of sub-clones of Ml3np2 containing negative
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strarnds of ASV Et. The filters used in panel c were subsequently hy-
bridized with radioactive E representing both strands of the 3.2kb
Ebo RI fragment of ASV EA; the figure illustrates an autoradiogram
obtained after the hybridization.
We determined the polarity of the ASV inserts in the genanes of
chimeric phage by hybridizing the fractionated DE with either cESrep
(which reacts principally with ASV nucleic acids of positive polarity)
or a radioactive arnd denatured preparation of the original 3.2kb ASV
DN fragment (which will react with ASV nucleic acids of both polari-
ties). Representative results are illustrated in Figure lc and d: the
genome of one recombinant phage hybridized with cEDNArep and thus con-
taimed ASV DNA of positive polarity (Figure lc); another reccbrinant
genome hybridized only with the cDNA maie with the 3.2kb fragment and
thus contained ASV DNA of negative polarity (Figure ld, right lane).
Subsequent analyses of rucleotide sequence confirmed these assign-
ments. Assured that we now possessed reccmbinant clones that could be
used for sequencing both strands of the ASV DMA fragment under study,
we proceeded with the sequence analysis.
Nucleotide sequence of the "c" domain of the ASV genome.
Figure 2 illustrates our experimental strategies for determining
the rucleotide sequence reported below. We relied principally upon
chain termination with dideoxynucleotides, as described by Sanger and
colleagues (22). We attenpted to inprove the accuracy of our results
by using at least two independent means to reproduce all of the se-
quence: usually, we sequenced overlapping regions by using two dif-
ferent primers in the terminator technique; in all regions, the se-
quence was determined in both polarities; and in a few instances, we
obtained supplementary data with the procedure of Maxam and Gilbert
(23). The 3.2kb fragment of IYNA used in the present analyses does not
include the last 65 nucleotides at the 3' terminus of the ASV gencme.
The sequence of these residues has been determined in a separate study
which will be reported elsewhere (R.S., manuscript in preparation),
and similar results have been obtained previously for the Prague sub-
group C strain of ASV (unpublished results of A.P.C. and J. Shine, and
personal comiunication from D.Schwartz and W. Gilbert); for clarity,
these data will be included in the discussion that follows.
The data obtained as outlined above provided us with the sequence
of 936 nucleotides at the 3' end of the SR-A ASV genome. Figure 3 il-
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Figure 2. Strategy for determining the nucleotide sequence of c".
The map coordinates begin arbitrarily with the first nucleotide
at the 5' boandary of the sequence determined in the present study and
extend beyond the junction between the cloned ASV CM and the EBo RI
site of the M13 vector EN. The map is aligned according to i po-
larity of the ASV genone (plus strand). Restriction sites are located
by arroas above the map: row II gives the positions of sites used in
sequencing the CM, row I gives additional sites deduced from the fi-
nal sequence. The arrows below the map define the regions sequen
with individal primers and fragments. The direction of the arrows
designates the polarity of [AIA used as teiplate in the terminator pro-
cedure: to the left, minus strand; to the right, plus strand. Addi-
tional designations: a, a sequence determined with the Maxam-Gilbert
technique; the fragment was labelled at the 3' terminus; b, a sequence
determined with the Maxam-Gilbert technique; the fragment was labelled
at the 5' terminus; c, a sequence obtained by using a synthetic primer
that initiates C synthesis 20 nucleotides to the right of the junc-
ticn between ASV IS and M13 Ws.
lustrates this sequence and joins it to the sequence found at the 5'
end of ASV IRNA (8,30); we chose this aligmennt for illustration in
order to facilitate discussion of important structural and functional
aspects of the nucleotide sequence. The gerxne of ASV has a direct
terminal redundancy (7,8); this sequence appears once in Figure 3 (po-
sitions 917-936), linking the 3' and 5' domains of the viral genane,
in accord with the structure of ENA transcribed from viral INA (R.S.,
manuscript in preparation).
Structural features of the sequence.
i.) The topography of the sequence was mct disturbed by molecular
cloning.
The SR-A ASV [M from which we prepared our sub-clones has been
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mapped extensively by site-specific cleavage with restriction endonu-
cleases (19). Our sequence contains all of the sites located previ-
ously by this means. In the process of preparing suitable primers for
sequencing with the terminator technique, we identified a number of
additicnal restriction sites; these also appear at appropriate posi-
ticns in the the final sequence. Since we prepared most of the pri-
mers from the original clcne of [NA in lambda phage rather than from
our sub-clones in M13, we are further assured that the sub-cloning did
mot cause major deletions or rearrangements in the DE. Figure 2 sum-
marizes the locations of cleavage sites for most of the available res-
triction endonucleases; a ccrplete catalogue of restriction sites
within the sequence is available from the authors on request.
ii.) Correlaticns with previous data.
Previous reports have described oligonucleotides obtained from
the "c" region by hydrolysis of ASV RA with Tl RNase (13-15). The
mst characteristic of these is an oligonucleotide whose cpmpoition
has proven to be remarkably constant among numerous strains of avian
retroviruses (13-15,31,32). The sequence illustrated in Figure 3 on-
tains this oligonucleotide at positions 904 to 915, a location that is
in accord with previous, less precise efforts to map the oligonucleo-
tide on the viral gename (13,14). We were able to detect other simi-
larities between the regions of the sequence reported here and oli-
gonucleotides described in the previous literature, but the hcmologies
were frequently inccmplete and are not located in Figure 3. These
findings conform to previous reports that changes in single nucleo-
tides are frequent among the genomes of related retroviruses
(13,14 ,31,32) .
iii.) The boundaries of "c".
The boundaries of "c" have in the past been defined operationally
by deletions that affect uncertain portions of src (13,27,31,32).
Here we define the dcmain as it is usually represented on formal maps
of the ASV genome (1,12): bounded on the right by the poly(A) at the
3' termirus of the ASV genome, and on the left by the termination of
src. The former is situated at position 936 in Figure 3. Can we lo-
cate the latter? Termination codons are scattered throughout two of
the three reading frames in Figure 3, but the third frame (designated
#1) is open from position 1 at the left of the sequence to position








61 - GGGGGAGAACCTGGTGTGCAAGGTGGCTGACTTTfG-GCTG CALCOUC2TCGAGGACAA - 120
121 - CGAGTACACAGCACGGCAAGGTGCCAAGTTCCCCATCAAGTGGACAGCCCCCGAGGCAGC - 180
al
Rib. T3 T2
181 - CCTCTATGGrCGGTTCACCATCAAGTCGGATGTCTGGTCCTTCGGCATCCTGCTGACTGA - 240
b3 s
T3 L
241 - GCTGACCACCAAGGGCCGGGTGCCATACCCAGGGATGGGCAACGGGGAGGTGCTGGACCG - 300
b4
T2
310 - GGTGGAGACGGGCTACCGCATGCCCT CCCGAGTGCCCCGAGTCGCTGCATGACT - 360
s ~ ~~a2a2
361 - TATG T CGAGGGACCCTGGAGGAGCGGCCCACTTTTCGAGCTACCTGCA - 420
a4 T2 Ti T2 Ti
421 - GGCCCAGCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGTGCGCGAGTAAAATTTA - 480
T3 T3 T2 T2
481 - AGCTACAACAAGGCAAGGCTTGACCGACAATTGCATGAAGAATCTGCTTAGGGTTAGGCG - 540
b5
Ti TI
541 - TTTTGCGCTGCTTCGCGATGTACGGGCCAGATATACGCGTATCT AGGGGACTAGGGTGT - 600
T2 T2 Rep. TI T1
601 - GTTTAGGCGAAAAGCGGGGCTTCGGTTGTACGCGGTTAGGAGTCCCCTCAGGATATAGTA - 660
_ . T2 T2
661 - GTTTCGCTTTTGCATAGGGAGGGGGAAATGTAGTCTTATGCAATACTCTTGTAGTCTTGC - 720
Ti TI T2 i *
721 - AACATGGTAACGATGAGTTAGCAACATACCTTACAAGGAGAGAAAAAGCACCGTGCATGC - 780
a5 a3
Ti Ti Ti
781 - CGATTGGTGGAAGTAAGGTGGTACGATCGTGCCTTATTAGGAAGGCAACAGACGGGTCTG - 840
a5
T3 b6 ' a6 Pro. T1 T2
841 - ACATGGATTGGACGAACCACTMATTCCGCATCGCAGAGATATTPTA - 900
AdT1 c T2 Red. oPlyA s -a -6- U~~~~~~~~ I a-
901 - CTCGATACAATAAACGCCATTTGACCATTCACCAATGGTTGCACCTaFGLATGGC - 960
8s-T b3 T T s b4
----L ---- Ti T2 T1 b5S
961 - TCGATTCCCTAACGCCTGI'4XAiCAAGGCTTCACT -3 term.1020
b4 b6
b5 bl
Figure 3. Nucleotide sequences in 3' and 5' d*mains of the ASV
gen9ma.
Te illustration joins sequences at the 3' and 5' ends of the ASV
genome as they appear in DM transcribed from the genIme by reverse
transcriptase. The 3' terminus of viral RTA (i.e., the site of po-
lyadenylation) is at position 936 (denoted by an arrow labelled p-
lyA), the 5' termirus at position 916 (denoted by c, for "capping
site"); the overlap between the 3' and 5' terminal sequences (posi-
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ticns 917-936, denoted Red.) represents the terminal redundancy of the
viral genomes, only one coy of which appears in the E synthesized by
reverse transcriptase (R.S., mauscript in preparation). The se-
quences were derived as follows: positions 1-868, from the present
study; positions 869-936, from a separate analysis of cloned ASV -t
that will be described elsewhere (R.S., manuscript in preparation);
and positions 937-1020, from previous analyses of EA transcribed from
the 5' end of the genrme of the Prague-C strain of ASV (30). Addi-
tional syrbols: i.) Tl, T2 and T3, termination codons in three reading
frames; ii.) s, regions of dyad syrmetry; iii.) Rib., a sequence that
is onnplemsntary bo the 3' end of 18S ribosoml I; iv.) Rep., a se-
quence repeated to the 5' side of src; v.) Pro., a possible coupoent
of the promoter for viral RH synthils; vi.) underlinings marked a"
denote olignxucleotides repeated within the 3' domain of the squence;
ruubers identify specific oligcnucleotides; vii.) underlinings marked
Obw denote oligonucleotides found in both the 3' and 5' domains of the
sequence; nuibers identify specific oligonucleotides; viii.) Ad., the
sequence alleged to signal processing and/or polyadenylation of nRAs
(positions 908-914); ix.) the underlining of positions 870-912 demar-
cates a region that can fold into a stable hairpin structure to in-
clude the alleged prooter sequence; and x.) the * at position 759
denotes an ambiguity in the sequence (G or T).
codon is likely to mark the 3' terminus of src; our provisional se-
quence of the entire src gene sustains this suggestion (work in pro-
gress). We conclude that the "c" region of SR-A ASV is probably 473
nucleotides in length. This conclusion is in accord with previous es-
timates obtained by mapping deletion mutants with restriction endonu-
cleases (27), whereas analysis of heteroduplexes by electron micros-
oopy had suggested a scmewhat larger value (33).
iv.) Can the "c" regicn be translated?
The distribution of termination codons within the "c" region pre-
cludes continuous translation from any of the reading frames. This
concl1vsion is based on the assunption that termination at the codon
UGA - which is the predani nant terminator codon in the sequence - is
not suppressed at an appreciable frequency; recent findings have
raised the possibility of such suppression in eukaryotic cells but
have not assessed its prevalence (34; and B. Cordell et al, manuscript
submitted). If translation is circumscribed by UGX codons, three re-
gions within "c" could nevertheless give rise to polypeptides of ap-
preciable size: (a) Positions 515-586; the polypeptide would consist
of 23 amino acids with the following sequence: met lys asn leu leu arg
val arg arg phe ala leu leu arg asp val arg ala arg tyr thr arg ile .
(b) Positions 558-677; the polypeptide would consist of 39 amino acids
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with the following sequence: met tyr gly pro asp ile arg val ser glu
gly thr arg val cys leu gly glu lys arg gly phe gly cys thr arg leu
gly val pro ser gly tyr ser ser phe ala phe ala. (c) Positions 777-
863; the polypeptide would consist of 28 amino acids with the follow-
ing sequence: met pro ile gly gly ser lys val val arg ser cys leu ile
arg lys ala thr asp gly ser asp met asp trp thr asn his. The first of
these possible polypeptides would be notably hydrephobic and basic,
the corrposition of the others would be less distinctive.
It is of course possible that FMA splicing could rearrange the
sequence of "c" so as to facilitate translation into a protein of rea-
sonable size, but we and others have failed to detect a suitable mTN
in infected cells (35,36). We therefore conclude that "c" is unlikely
to encode a protein larger than 39 amimo acids unless UGA codons
within the sequence are suppressed in eukaryotic cells. Previous pro-
posals that translation from "c" might acoount for leuke4mogenesis are
probably incorrect. It remains possible, however, that the danain
gives rise to at least one of the small polypeptides described above;
the factors that stinulate growth of eukaryotic cells include proteins
of this size (37).
v.) Polyadenylation of viral RN&.
The sequence AAUAAA appears near the 3' terminus of most, if not
all, eukarytic mRns and is thought to be the signal for sane or all
of the events that generate the polyaderylated 3' terminus of mature
nmik (38,39). The sequence of "c" contains this alleged signal at po-
sitions 909-914, or 23-28 residues from the 3' terminus of the viral
genome as represented in Figure 3. This location is similar to that
found in other eukaryotic mRAs (38-42).
vi.) A signal for the initiation of viral RNA synthesis?
A portion of "c" is contained within the 330bp terminal redundan-
cy that brackets the integrated provirus of ASV and allegedly harbors
the promoter for viral RMA synthesis (10,11). We have isolated the
terminal redundancy and analysed its nucleotide sequence; the results
of these studies will be reported and discussed in full elsewhere
(R.S., manuscript in preparation). Here we explore the relationship
of these findings to the corposition of "c".
In Figure 3, we have aligned the nucleotide sequences as they oc-
cur in the terminal redundancy, with the 3' end of "c" fused to the 5'
end of the viral genome (10,11,17). According to this scheme, viral
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R4A synthesis might begin at the 5' terminus of the genome proper (po-
siticn 917) in response to signals possibly contained within the 3'
domain of the terminal redundancy. We have therefore searched the se-
quence of "c" for oligcnucleotides implicated previously in the ini-
tiaticn of nmRN synthesis by eukaryotic cells (38-42). A sequence
bearing features of the canonical eukaryotic "promoter site" occurs at
positicrs 880 to 893 in Figure 3, 24 nucleotides from the alleged site
of initiation of RNA synthesis. The candidate signal for initiation
can be included in a large hair-pin structure that spans positions 881
to 912 (see Figure 3). Several elements of dyad synmmetry (denoted s
in Figure 3) are located downstrean from the sequence. These findings
are all in accord with previous descriptions of sites where the syn-
thesis of eukaryotic nRN is initiated and encourage us to examine
more rigorously the possibility that the promoter for ASV RNA syn-
thesis resides in the terminal redundancy of viral DNA.
vii.) Secondary structure in "c".
Conputer-assisted analysis of the sequence reported here revealed
ca. 200 possibilities for the formation of hairpin duplexes containing
eight or more base-paired nucleotides (not illustrated). We have no
means at present by which to discern whether any of these structures
actually exist in the native RNA, or whether any are of functional
significance. We also found a number of regions that display appreci-
able dyad synmnetry; Figure 3 illustrates ten of the more extensive ex-
anples.
viii.) A repeated nucleotide sequence that flanks src.
By carparison of the sequence presented here with our unpublished
data, we have identified a sequence of at least twenty nucleotides
(positions 643 to 662) that is repeated directly and most likely pre-
cisely in an apparently untranslated region to the 5' side of src.
Moreover, the precise repeats are each extended in both directions by
adjacent, partially repeated (90%) sequences caposed of ca. 20 nu-
cleotides. Hence, the repeated domains include at least 60 nucleo-
tides. We tentatively propose that this repeated sequence might medi-
ate deletion of src by hmologous recombination within the ASV genome,
or by some other mechanism. This proposal could account for the re-
markable frequency with which src is deleted during the propagation of
nmst strains of ASV (12).
ix.) Homology with 18S ribosomal IM.
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It is thought that canplementary interactions between mRA and
18S ribosomal RNA may figure in the synthesis of proteins in eukaryot-
ic cells (43). We therefore searched the nucleotide sequence in Fig-
ure 3 for relationships to 18S ribosomal iA and found that the se-
quence at positions 215 through 228 is cosplemantary at 11 out of 14
nucleotides to the sequence at the 3' terminus of 18S ribosonal RNA.
The significance of this finding is presently moot because we have no
evidence that ribosane binding occurs anywhere within the damain of
c.
x.) Homologies with NA.
A nurrber of tRIAs from the host cell can base-pair with the
genome of ASV (44,45). The significance and location of this base-
pairing has been established in only one instance - t.WTrp, which is
situated near the 5' terminus of the viral genane and serves as primer
for reverse transcriptase (6). (Available data do not exclude the
possiblility that tTrP also binds to the genome at other sites.)
We searched the sequence in Figure 3 for relationships to t1Trp and
discovered non-random homologies with the sequence of tRATrp, its
inversion, the complemmt of tNTrp, and its inversion; these homolo-
gies are illustrated in Figure 4. We also searched published se-
quences of the untranslated regions of globin mRNA and SV40 DNA for
similar relationships to tRtTrp and faod none. Other investigators,
hwever, have reported partial homologies with t1Ms in the gene for
23S ribosomal MA of bacteria (46,47), in sequences that bracket the
gene for cytochrome II oxidase in mintochondrial DNtA of mice (38), and
in the genane of polycmna virus (48).
xi.) Homologies with the 5' end of the ASV genome.
The genane of ASV contains a direct terminal redundancy (7,8).
This fact pronpted us to search for further evidence of relatedness
between the 3' and 5' domains of viral RNA. Although our search was
constrained by the limited amount of data available for the 5' end of
the viral genane, we nevertheless found six regions of appreciable
homology between the 5' and 3' domains (designated "b" in Figure 3).
The significance of these findings is presently noot.
xii.) Repeated nucleotide sequences within the 3' domain.
The sequence from position 1 to 917 in Figure 3 contains six oli-
gonucleotides of various sizes that are each partially repeated within
the sequence (denoted by "a" in the figure). The repetitions were
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a) 5' - GACCTCGTGGCGCAACGGTAGCGCGTCTGACTCCAGATCAGAAGGCTGCGTGTTCGMTCACGTCGGGGTCACCA -3'
277 285 186 200
511 523
785 826
b) 5'- CTGGAGCACCGCGTTGCCATCGCGCAGACTGAGGTCTAGTCTTCCGACGCACAAGCTTAGTGCAGCCCCAGTGGT -3'
315 332 782 788
188 178 408 428
86 101 284 276
105 113
C) 5'- ACCACTGGGGCTGCACTAAGCTTGTGCGTCGGM.GACTAGACCTCAGTCTGCGCGATGGCAACGCGGTGCTCCAG -3'




d) 5'- TGGTGACCCCGACGTGATTCGAACACGCAGCCTTCTGATCTGGAGTCAGACGCGCTACCGTTGCGCCACGAGGTC -3'
29 40 201 - 212
167 176 306 - 318
337 347
Figujp4. Houlogies between the 3' domain of the ASV genane and
tRN~A
Underlinings denote sequences that are also present in the se-
quence illustrated in Figure 3; nuitr s denote the positions in Figure
3. a) The sequence of chicken tR , rendered in deoxynucleotides;
b) the cczplement of the sequence in a; c) inversion of the sequence
in a; d) inversion of the sequence in b.
fcund both within "c" and in the portion of the sequence that we be-
lieve to be the 3' domain of src.
Concluding remarks
It appears unlikely that "c" encodes a protein, but the sequence
may nevertheless serve essential functions in viral replication: pre-
vious reconrbination analyses indicated that the ability of avian re-
troviruses to replicate to high titers segregated with a particular
form of "c" (16), and the data presented here inplicate "c" in several
crucial portions of the viral life cycle. To date, three forms of "c"
have been identified in avian retroviruses: one whose prototype is
carried by ASV and related viruses; a second whose prototype is in the
genome of the endogenous avian retrovirus, RAV-O (16,49); and a third,
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recently identified in the genane of avian myeloblastosis virus and
one of its helper viruses (unpublished results of T. Gonda andl
J.M.B.). It may prove instructive to caipare the nucleotide sequences
of these three forms of "c".
The avian leukosis viruses readily induce lynphomas in birds, yet
apparently do not have a genetic locus devoted specifically to on-
cogenesis (1,12). Moreover, deletion of src from the genane of ASV
deprives the virus of its ability bo induce sarcomas, but gives rise
to a leukosis virus (12,50). These findings have been attributed in
the past to the possibility that "c" might encode an oncogenic pro-
tein; the present report calls this explanation into serious doubt.
It remains possible, however, that "c" participates in leukemogenesis.
We have argued elsewhere that the promoter for retrovirus RNA syn-
thesis may, on occasion, induce transcription of otherwise silent cel-
lular genes (in the manner of the "floating promoter" effect of some
tranposable elements in bacteria (51)), and that induction of cellular
genes in this manner could contribute to both leukenogenesis and co-
carcinogenesis by retroviruses that do not possess specific oncogenes
(52). If this suggestion is correct, and if the cOoposition of "c"
bears on the relative efficiency of retrovirus promoters, then sane
forms of "c" may be associated with leukenuogenesis and others not.
Again, orparative studies of "c" in the genanes of leukemogenic and
non-leukemogenic avian retroviruses may be informative.
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